None
None, None [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared (RPHM) to it's peer group, including competitors as well as it's industry.
All monetary values in mil. except volume - volume is in thousands.
Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- - Average | - - | - - | - - | - - | |||||||||||||||
Maximum | - - | - - | - - | - - | |||||||||||||||
Minimum | - - | - - | - - | - - | |||||||||||||||
Vir Biotechnology, Inc. VIR | 7.12 | 0.17 2.45% | 891 vs. 1,013 | 980.00 | 56.00 | -65.00 | -111.00 | -303.00 | -0.4800 | -5.2847 | 0.0000 | 0.9188 | -1.1579 | -0.0422 | -0.0364 | 12.4686 | 137.00 | ||
Royalty Pharma plc RPRX | 26.43 | 0.03 0.11% | 2,377 vs. 2,328 | 11,742.00 | 567.00 | 4.00 | 583.00 | 2,427.00 | 0.0106 | 701.8537 | 0.0070 | -0.0275 | 0.0084 | 0.0007 | 0.0003 | 12.4802 | 444.00 | ||
Apellis Pharmaceuticals, Inc. APLS | 30.77 | 3.02 10.88% | 2,660 vs. 2,876 | 3,827.00 | 172.00 | -66.00 | -133.00 | -2,903.00 | -0.5400 | -27.6326 | 0.0000 | 0.8802 | -0.3855 | -0.2491 | -0.0798 | 2.7985 | 124.00 |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.